Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership2,318,110 shares
Latest Disclosed Value $ 29,708,722
Dimensional Fund Advisors Lp reports 19.99% increase in ownership of NTLA / Intellia Therapeutics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 2,318,110 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $29,718,170 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,931,849 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 19.99% during the quarter. The current value of the position is $30,181,792 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,318,110 386,261 19.99 29,709 71.06 0.0013
2026-02-12 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,931,849 174,555 9.93 17,367 -42.77 0.0036
2025-11-12 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,757,294 -109,015 -5.84 30,346 73.35 0.0065
2025-08-12 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,866,309 -101,857 -5.18 17,507 25.08 0.0041
2025-05-13 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,968,166 -8,046 -0.41 13,997 -39.26 0.0035
2025-02-13 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,976,212 528,962 36.55 23,042 -22.53 0.0055
2024-11-07 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,447,250 122,689 9.26 29,743 0.32 0.0072
2024-08-09 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,324,561 98,865 8.07 29,648 -12.07 0.0077
2024-05-10 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,225,696 54,867 4.69 33,719 -5.56 0.0091
2024-02-07 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,170,829 60,748 5.47 35,704 1.72 0.0104
2023-11-09 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,110,081 83,840 8.17 35,103 -16.13 0.0115
2023-08-09 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,026,241 205,749 25.08 41,851 36.87 0.0133
2023-05-12 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 820,492 -99,584 -10.82 30,578 95,456.25 0.0103
2023-02-09 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 920,076 9,968 1.10 32 -99.94 0.0095
2022-11-10 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 910,108 -8,790 -0.96 50,929 7.08 0.0196
2022-08-12 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 918,898 -26,849 -2.84 47,561 -30.80 0.0171
2022-05-13 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 945,747 -111,663 -10.56 68,727 -45.03 0.0212
2022-02-09 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,057,410 -83,348 -7.31 125,031 -18.30 0.0378
2021-11-12 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,140,758 437 0.04 153,038 -17.10 0.0493
2021-08-12 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,140,321 151,568 15.33 184,610 132.69 0.0584
2021-05-14 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 988,753 4,280 0.43 79,338 48.13 0.0262
2021-03-08 2020-12-31 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 984,473 -31,859 -3.13 53,560 165.03 0.0193
2021-02-11 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 984,473 -31,859 53,560 19,343.0251
2020-11-12 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,016,332 -52,194 -4.88 20,209 -10.02 0.0086
2020-08-13 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,068,526 44,022 4.30 22,459 79.24 0.0099
2020-05-14 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,024,504 15,187 1.50 12,530 -15.38 0.0065
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,009,317 41,937 4.34 14,807 14.65 0.0054
2019-11-12 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 967,380 97,150 11.16 12,915 -9.34 0.0050
2019-08-13 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 870,230 246,964 39.62 14,245 33.82 0.0055
2019-08-12 2019-03-31 13F/A-2 INTELLIA THERAPEUTICS COM 45826J105 623,266 363,007 139.48 10,645 199.69 0.0042
2019-05-10 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 623,266 363,007 10,645
2019-02-26 2018-12-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 260,259 217,071 502.62 3,552 187.38 0.0016
2019-02-13 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 260,259 217,071 3,552
2018-11-13 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 43,188 43,188 1,236 0.0005
2018-05-11 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 0 -40,009 -100.00 0 -100.00
2018-02-12 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 40,009 -3,400 -7.83 769 -28.73 0.0003
2017-11-13 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 43,409 0 0.00 1,079 55.25 0.0005
2017-08-11 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 43,409 43,409 695 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.